HBV/HCV/HIV

Question 1

Treatment for HCV

Answer 1

First line: DAA Combination
Other: DAA Combination + RBV

Question 2

DAAs

Answer 2

Glecaprevir/pibrentasvir
Sofosbuvir/velpatasvir
Sofosbuvir/velpatasvir/voxilaprevir
Sofosbuvir/ledipasvir
Sofosbuvir
Elbasvir/grazoprevir

Question 3

NS3/4A Protease Inhibitors

Answer 3

Glecaprevir
Grazoprevir
Voxilaprevir
(-previr)

Question 4

NS5A Replication Complex Inhibitors

Answer 4

Elbasvir
Ledipasvir
Pibrentasvir
Velpatasvir
(-asvir)

Question 5

NS5B Polymerase Inhibitors

Answer 5

Sofosbuvir
(-buvir)

Question 6

Mavyret

Answer 6

Glecaprevir/pibrentasvir

Question 7

Epclusa

Answer 7

Sofosbuvir/velpatasvir

Question 8

Treatment for HBV

Answer 8

PEG-IFN or NRTI

Question 9

NRTIs

Answer 9

Tenofovir disoproxil fumarate
Tenofovir alafenamide
Entecavir
Lamivudine
Adefovir

Question 10

Viread

Answer 10

Tenofovir disoproxil fumarate (TDF)

Question 11

Vemlidy

Answer 11

Tenofovir alafenamide (TAF)

Question 12

Baraclude

Answer 12

Entecavir

Question 13

Epivir HBV

Answer 13

Lamivudine

Question 14

Treatment for HIV

Answer 14

Preferred: 1 INSTI + 2 NRTIs
Alternatives: 1 base (PI, NNRTI, INSTI) + 2 NRTIs

Question 15

Preferred Initial ART for HIV

Answer 15

Biktarvy (Bictegravir/Emtricitabine/TAF)

Triumeq (Dolutegravir/Abacavir/Lamivudine)

Dovato (Dolutegravir/Lamivudine)

Tivicay + Truvada (Dolutegravir + Emtricitabine/TDF)

Tivicay + Descovy (Dolutagravir + Emtricitabine/TAF)

Question 16

Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)

Answer 16

Abacavir
Emtricitabine
Lamivudine
TDF
TAF
Zidovudine

Question 17

Integrase Strand Transfer Inhibitors (INSTIs)

Answer 17

Bictegravir
Cabotegravir
Dolutegravir
Elvitegravir
Raltegravir
(-tegravir)

Question 18

Apretude

Answer 18

Cabotegravir

Question 19

Tivicay

Answer 19

Dolutegravir

Question 20

Isentress, Isentress HD

Answer 20

Raltegravir

Question 21

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Answer 21

Efavirenz
Rilpivirine
Doravirine
Etravirine
Nevirapine
(-vir-)

Question 22

Protease Inhibitors (PIs)

Answer 22

Atazanavir
Darunavir
Fosamprenavir
Lopinavir/ritonavir
Tipranavir
(-navir)

Question 23

Reyataz

Answer 23

Atazanavir

Question 24

Prezista

Answer 24

Darunavir

Question 25

Boosters

Answer 25

Ritonavir Cobicistat

Question 26

Norvir

Answer 26

Ritonavir

Question 27

Tybost

Answer 27

Cobicistat

Question 28

Biktarvy (INSTI-based)

Answer 28

Bictegravir/emtricitabine/TAF

Question 29

Cabenuva (INSTI-based)

Answer 29

Cabotegravir/rilpivirine

Question 30

Triumeq (INSTI-based)

Answer 30

Dolutegravir/abacavir/lamivudine

Question 31

Dovato (INSTI-based)

Answer 31

Dolutegravir/lamivudine

Question 32

Stribild (INSTI-based)

Answer 32

Elvitegravir/cobicistat/emtricitabine/TDF

Question 33

Genvoya (INSTI-based)

Answer 33

Elvitegravir/cobicistat/emtricitabine/TAF

Question 34

Complera (NNRTI-based)

Answer 34

Rilpivirine/emtricitabine/TDF

Question 35

Odefsey (NNRTI-based)

Answer 35

Rilpivirine/emtricitabine/TAF

Question 36

Symfi/Symfi LO (NNRTI-based)

Answer 36

Efavirenz/lamivudine/TDF

Question 37

Symtuza (PI-based)

Answer 37

Darunavir/cobicistat/emtricitabine/TAF

Question 38

Epzicom

Answer 38

Abacavir/lamivudine

Question 39

Descovy

Answer 39

Emtricitabine/TAF

Question 40

Truvada

Answer 40

Emtricitabine/TDF

Question 41

PrEP Treatment

Answer 41

Truvada or Descovy Daily

Question 42

PEP Treatment

Answer 42

Start within 72 hours and take for 28 days Truvada (if CrCl 60+) + Dolutegravir (Tivicay) or Raltegravir (Isentress)